Ontogenesis, LLC
Deerfield, IL, US· latest recorded location
Ontogenesis, LLC is named on 3 US grants and 7 published applications in this corpus. Its most frequent classification is C07D (Heterocyclic compounds).
- Granted patents
- 3
- Published applications
- 7
- Inventors
- 1
- Granted in 2026 so far
- 0
- Most recent grant
- 11 Apr 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 0 | 3 |
| 2018 | 0 | 1 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
By publication year.
Technology areas
Share of 10 documents
Recent patents
- Multi-tyrosine kinase inhibitors derivatives and methods of use11 Apr 2023US 11,623,917 B2
- Multi-tyrosine kinase inhibitors derivatives and methods of use26 Jan 2021US 10,899,712 B2
- Multi-tyrosine kinase inhibitors derivatives and methods of use5 Nov 2019US 10,464,902 B1
- Multi-Tyrosine Kinase Inhibitors Derivatives and Methods of Use22 Apr 2021US 2021/0114986 A1
- Multi-Tyrosine Kinase Inhibitors Derivatives and Methods of Use7 Nov 2019US 2019/0337898 A1
- Multi-Tyrosine Kinase Inhibitors Derivatives and Methods of Use11 Jan 2018US 2018/0009758 A1
- Multi-Tyrosine Kinase Inhibitors Derivatives and Methods of Use25 May 2017US 2017/0143688 A1
- Multi-Tyrosine Kinase Inhibitors Derivatives and Methods of Use27 Apr 2017US 2017/0112821 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.